APO RESEARCH · REPORT
Biopsy Forceps
Biopsy Forceps is an indispensable medical device for collecting biopsies during minimally invasive GI and urologic endoscopy and other medical examination.
Product & engineering
Understand the product.
Biopsy Forceps is an indispensable medical device for collecting biopsies during minimally invasive GI and urologic endoscopy and other medical examination.
In this report, we statistic Rigid Biopsy Forceps and Flexible Biopsy Forceps, But we focus on the Flexible Biopsy Forceps.
Selected research
Market Outlook & Growth Opportunities
Global Biopsy Forceps Market Outlook and Growth Opportunities 2026
Market perspective
Biopsy Forceps is an indispensable medical device for collecting biopsies during minimally invasive GI and urologic endoscopy and other medical examination.
In this report, we statistic Rigid Biopsy Forceps and Flexible Biopsy Forceps, But we focus on the Flexible Biopsy Forceps.
The major players in global Biopsy Forceps market include OLYMPUS, Stryker, KARL STORZ, etc. The top 3 players occupy about 30% shares of the global market. North America and Europe are main markets, they occupy about 60% of the global market. Flexible Biopsy Forceps is the main type, with a share over 90%. Laparoscopy is the main application, which holds a share about 50%.
Read the full market overview
This report provides an overview of the global Biopsy Forceps market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Biopsy Forceps and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Biopsy Forceps sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Biopsy Forceps market size, projected growth trends, production technologies, key applications, and end-use industries.
Biopsy Forceps Segment by Company
OLYMPUS
Boston Scientific
KARL STORZ
Cook Medical
PENTAX (HOYA)
Argon Medical
ConMed
Fujifilm
Cordis(J&J)
Micro Tech
Wilson
Alton
Tiansong
Jiuhong
JingRui
Stryker
Richard-Wolf
Rudolf
Aesculap
Jinzhong
Xinhua
Tonglu Medical
Guangdian
Shenda
Kangji
Jinbaolong
Biopsy Forceps Segment by Type
Rigid Biopsy Forceps
Flexible Biopsy Forceps
Biopsy Forceps Segment by Application
Laparoscopy
Endoscopy Detect for Respiratory Tract
Endoscopy Detect for Digestive Tract
Other
Biopsy Forceps Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Biopsy Forceps status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Biopsy Forceps market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Biopsy Forceps significant trends, drivers, influence factors in global and regions.
6. To analyze Biopsy Forceps competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biopsy Forceps market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biopsy Forceps and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biopsy Forceps.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Biopsy Forceps market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biopsy Forceps industry.
Chapter 3: Detailed analysis of Biopsy Forceps manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Biopsy Forceps in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Biopsy Forceps in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Rigid Biopsy Forceps
- Flexible Biopsy Forceps
Applications
- Laparoscopy
- Endoscopy Detect for Respiratory Tract
- Endoscopy Detect for Digestive Tract
- Other
Companies covered
- OLYMPUS
- Boston Scientific
- KARL STORZ
- Cook Medical
- PENTAX (HOYA)
- Argon Medical
- ConMed
- Fujifilm
- Cordis(J&J)
- Micro Tech
- Wilson
- Alton
- Tiansong
- Jiuhong
- JingRui
- Stryker
- Richard-Wolf
- Rudolf
- Aesculap
- Jinzhong
- Xinhua
- Tonglu Medical
- Guangdian
- Shenda
- Kangji
- Jinbaolong
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Biopsy Forceps Sales Value (2021-2032)
- 1.2.2 Global Biopsy Forceps Sales Volume (2021-2032)
- 1.2.3 Global Biopsy Forceps Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Biopsy Forceps Market Dynamics
- 2.1 Biopsy Forceps Industry Trends
- 2.2 Biopsy Forceps Industry Drivers
- 2.3 Biopsy Forceps Industry Opportunities and Challenges
- 2.4 Biopsy Forceps Industry Restraints
3 Biopsy Forceps Market by Company
- 3.1 Global Biopsy Forceps Company Revenue Ranking in 2025
- 3.2 Global Biopsy Forceps Revenue by Company (2021-2026)
- 3.3 Global Biopsy Forceps Sales Volume by Company (2021-2026)
- 3.4 Global Biopsy Forceps Average Price by Company (2021-2026)
- 3.5 Global Biopsy Forceps Company Ranking (2024-2026)
- 3.6 Global Biopsy Forceps Company Manufacturing Base and Headquarters
- 3.7 Global Biopsy Forceps Company Product Type and Application
- 3.8 Global Biopsy Forceps Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Biopsy Forceps Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Biopsy Forceps Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Biopsy Forceps Market by Type
- 4.1 Biopsy Forceps Type Introduction
- 4.1.1 Rigid Biopsy Forceps
- 4.1.2 Flexible Biopsy Forceps
- 4.2 Global Biopsy Forceps Sales Volume by Type
- 4.2.1 Global Biopsy Forceps Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Biopsy Forceps Sales Volume by Type (2021-2032)
- 4.2.3 Global Biopsy Forceps Sales Volume Share by Type (2021-2032)
- 4.3 Global Biopsy Forceps Sales Value by Type
- 4.3.1 Global Biopsy Forceps Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Biopsy Forceps Sales Value by Type (2021-2032)
- 4.3.3 Global Biopsy Forceps Sales Value Share by Type (2021-2032)
5 Biopsy Forceps Market by Application
- 5.1 Biopsy Forceps Application Introduction
- 5.1.1 Laparoscopy
- 5.1.2 Endoscopy Detect for Respiratory Tract
- 5.1.3 Endoscopy Detect for Digestive Tract
- 5.1.4 Other
- 5.2 Global Biopsy Forceps Sales Volume by Application
- 5.2.1 Global Biopsy Forceps Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Biopsy Forceps Sales Volume by Application (2021-2032)
- 5.2.3 Global Biopsy Forceps Sales Volume Share by Application (2021-2032)
- 5.3 Global Biopsy Forceps Sales Value by Application
- 5.3.1 Global Biopsy Forceps Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Biopsy Forceps Sales Value by Application (2021-2032)
- 5.3.3 Global Biopsy Forceps Sales Value Share by Application (2021-2032)
6 Biopsy Forceps Regional Sales and Value Analysis
- 6.1 Global Biopsy Forceps Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Biopsy Forceps Sales by Region (2021-2032)
- 6.2.1 Global Biopsy Forceps Sales by Region: 2021-2026
- 6.2.2 Global Biopsy Forceps Sales by Region (2027-2032)
- 6.3 Global Biopsy Forceps Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Biopsy Forceps Sales Value by Region (2021-2032)
- 6.4.1 Global Biopsy Forceps Sales Value by Region: 2021-2026
- 6.4.2 Global Biopsy Forceps Sales Value by Region (2027-2032)
- 6.5 Global Biopsy Forceps Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Biopsy Forceps Sales Value (2021-2032)
- 6.6.2 North America Biopsy Forceps Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Biopsy Forceps Sales Value (2021-2032)
- 6.7.2 Europe Biopsy Forceps Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Biopsy Forceps Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Biopsy Forceps Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Biopsy Forceps Sales Value (2021-2032)
- 6.9.2 South America Biopsy Forceps Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Biopsy Forceps Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Biopsy Forceps Sales Value Share by Country, 2025 VS 2032
7 Biopsy Forceps Country-level Sales and Value Analysis
- 7.1 Global Biopsy Forceps Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Biopsy Forceps Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Biopsy Forceps Sales by Country (2021-2032)
- 7.3.1 Global Biopsy Forceps Sales by Country (2021-2026)
- 7.3.2 Global Biopsy Forceps Sales by Country (2027-2032)
- 7.4 Global Biopsy Forceps Sales Value by Country (2021-2032)
- 7.4.1 Global Biopsy Forceps Sales Value by Country (2021-2026)
- 7.4.2 Global Biopsy Forceps Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Biopsy Forceps Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Biopsy Forceps Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Biopsy Forceps Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Biopsy Forceps Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Biopsy Forceps Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Biopsy Forceps Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Biopsy Forceps Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Biopsy Forceps Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Biopsy Forceps Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Biopsy Forceps Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Biopsy Forceps Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Biopsy Forceps Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Biopsy Forceps Sales Value Growth Rate (2021-2032)
- 7.9.2 France Biopsy Forceps Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Biopsy Forceps Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Biopsy Forceps Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Biopsy Forceps Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Biopsy Forceps Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Biopsy Forceps Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Biopsy Forceps Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Biopsy Forceps Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Biopsy Forceps Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Biopsy Forceps Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Biopsy Forceps Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Biopsy Forceps Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Biopsy Forceps Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Biopsy Forceps Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Biopsy Forceps Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Biopsy Forceps Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Biopsy Forceps Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Biopsy Forceps Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Biopsy Forceps Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Biopsy Forceps Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Biopsy Forceps Sales Value Growth Rate (2021-2032)
- 7.16.2 China Biopsy Forceps Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Biopsy Forceps Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Biopsy Forceps Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Biopsy Forceps Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Biopsy Forceps Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Biopsy Forceps Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Biopsy Forceps Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Biopsy Forceps Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Biopsy Forceps Sales Value Growth Rate (2021-2032)
- 7.19.2 India Biopsy Forceps Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Biopsy Forceps Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Biopsy Forceps Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Biopsy Forceps Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Biopsy Forceps Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Biopsy Forceps Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Biopsy Forceps Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Biopsy Forceps Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Biopsy Forceps Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Biopsy Forceps Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Biopsy Forceps Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Biopsy Forceps Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Biopsy Forceps Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Biopsy Forceps Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Biopsy Forceps Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Biopsy Forceps Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Biopsy Forceps Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Biopsy Forceps Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Biopsy Forceps Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Biopsy Forceps Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Biopsy Forceps Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Biopsy Forceps Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Biopsy Forceps Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Biopsy Forceps Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Biopsy Forceps Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Biopsy Forceps Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Biopsy Forceps Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Biopsy Forceps Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Biopsy Forceps Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Biopsy Forceps Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Biopsy Forceps Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Biopsy Forceps Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Biopsy Forceps Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Biopsy Forceps Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Biopsy Forceps Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Biopsy Forceps Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Biopsy Forceps Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Biopsy Forceps Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Biopsy Forceps Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Biopsy Forceps Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Biopsy Forceps Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 OLYMPUS
- 8.1.1 OLYMPUS Company Information
- 8.1.2 OLYMPUS Business Overview
- 8.1.3 OLYMPUS Biopsy Forceps Sales, Value and Gross Margin (2021-2026)
- 8.1.4 OLYMPUS Biopsy Forceps Product Portfolio
- 8.1.5 OLYMPUS Recent Developments
- 8.2 Boston Scientific
- 8.2.1 Boston Scientific Company Information
- 8.2.2 Boston Scientific Business Overview
- 8.2.3 Boston Scientific Biopsy Forceps Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Boston Scientific Biopsy Forceps Product Portfolio
- 8.2.5 Boston Scientific Recent Developments
- 8.3 KARL STORZ
- 8.3.1 KARL STORZ Company Information
- 8.3.2 KARL STORZ Business Overview
- 8.3.3 KARL STORZ Biopsy Forceps Sales, Value and Gross Margin (2021-2026)
- 8.3.4 KARL STORZ Biopsy Forceps Product Portfolio
- 8.3.5 KARL STORZ Recent Developments
- 8.4 Cook Medical
- 8.4.1 Cook Medical Company Information
- 8.4.2 Cook Medical Business Overview
- 8.4.3 Cook Medical Biopsy Forceps Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Cook Medical Biopsy Forceps Product Portfolio
- 8.4.5 Cook Medical Recent Developments
- 8.5 PENTAX (HOYA)
- 8.5.1 PENTAX (HOYA) Company Information
- 8.5.2 PENTAX (HOYA) Business Overview
- 8.5.3 PENTAX (HOYA) Biopsy Forceps Sales, Value and Gross Margin (2021-2026)
- 8.5.4 PENTAX (HOYA) Biopsy Forceps Product Portfolio
- 8.5.5 PENTAX (HOYA) Recent Developments
- 8.6 Argon Medical
- 8.6.1 Argon Medical Company Information
- 8.6.2 Argon Medical Business Overview
- 8.6.3 Argon Medical Biopsy Forceps Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Argon Medical Biopsy Forceps Product Portfolio
- 8.6.5 Argon Medical Recent Developments
- 8.7 ConMed
- 8.7.1 ConMed Company Information
- 8.7.2 ConMed Business Overview
- 8.7.3 ConMed Biopsy Forceps Sales, Value and Gross Margin (2021-2026)
- 8.7.4 ConMed Biopsy Forceps Product Portfolio
- 8.7.5 ConMed Recent Developments
- 8.8 Fujifilm
- 8.8.1 Fujifilm Company Information
- 8.8.2 Fujifilm Business Overview
- 8.8.3 Fujifilm Biopsy Forceps Sales, Value and Gross Margin (2021-2026)
- 8.8.4 Fujifilm Biopsy Forceps Product Portfolio
- 8.8.5 Fujifilm Recent Developments
- 8.9 Cordis(J&J)
- 8.9.1 Cordis(J&J) Company Information
- 8.9.2 Cordis(J&J) Business Overview
- 8.9.3 Cordis(J&J) Biopsy Forceps Sales, Value and Gross Margin (2021-2026)
- 8.9.4 Cordis(J&J) Biopsy Forceps Product Portfolio
- 8.9.5 Cordis(J&J) Recent Developments
- 8.10 Micro Tech
- 8.10.1 Micro Tech Company Information
- 8.10.2 Micro Tech Business Overview
- 8.10.3 Micro Tech Biopsy Forceps Sales, Value and Gross Margin (2021-2026)
- 8.10.4 Micro Tech Biopsy Forceps Product Portfolio
- 8.10.5 Micro Tech Recent Developments
- 8.11 Wilson
- 8.11.1 Wilson Company Information
- 8.11.2 Wilson Business Overview
- 8.11.3 Wilson Biopsy Forceps Sales, Value and Gross Margin (2021-2026)
- 8.11.4 Wilson Biopsy Forceps Product Portfolio
- 8.11.5 Wilson Recent Developments
- 8.12 Alton
- 8.12.1 Alton Company Information
- 8.12.2 Alton Business Overview
- 8.12.3 Alton Biopsy Forceps Sales, Value and Gross Margin (2021-2026)
- 8.12.4 Alton Biopsy Forceps Product Portfolio
- 8.12.5 Alton Recent Developments
- 8.13 Tiansong
- 8.13.1 Tiansong Company Information
- 8.13.2 Tiansong Business Overview
- 8.13.3 Tiansong Biopsy Forceps Sales, Value and Gross Margin (2021-2026)
- 8.13.4 Tiansong Biopsy Forceps Product Portfolio
- 8.13.5 Tiansong Recent Developments
- 8.14 Jiuhong
- 8.14.1 Jiuhong Company Information
- 8.14.2 Jiuhong Business Overview
- 8.14.3 Jiuhong Biopsy Forceps Sales, Value and Gross Margin (2021-2026)
- 8.14.4 Jiuhong Biopsy Forceps Product Portfolio
- 8.14.5 Jiuhong Recent Developments
- 8.15 JingRui
- 8.15.1 JingRui Company Information
- 8.15.2 JingRui Business Overview
- 8.15.3 JingRui Biopsy Forceps Sales, Value and Gross Margin (2021-2026)
- 8.15.4 JingRui Biopsy Forceps Product Portfolio
- 8.15.5 JingRui Recent Developments
- 8.16 Stryker
- 8.16.1 Stryker Company Information
- 8.16.2 Stryker Business Overview
- 8.16.3 Stryker Biopsy Forceps Sales, Value and Gross Margin (2021-2026)
- 8.16.4 Stryker Biopsy Forceps Product Portfolio
- 8.16.5 Stryker Recent Developments
- 8.17 Richard-Wolf
- 8.17.1 Richard-Wolf Company Information
- 8.17.2 Richard-Wolf Business Overview
- 8.17.3 Richard-Wolf Biopsy Forceps Sales, Value and Gross Margin (2021-2026)
- 8.17.4 Richard-Wolf Biopsy Forceps Product Portfolio
- 8.17.5 Richard-Wolf Recent Developments
- 8.18 Rudolf
- 8.18.1 Rudolf Company Information
- 8.18.2 Rudolf Business Overview
- 8.18.3 Rudolf Biopsy Forceps Sales, Value and Gross Margin (2021-2026)
- 8.18.4 Rudolf Biopsy Forceps Product Portfolio
- 8.18.5 Rudolf Recent Developments
- 8.19 Aesculap
- 8.19.1 Aesculap Company Information
- 8.19.2 Aesculap Business Overview
- 8.19.3 Aesculap Biopsy Forceps Sales, Value and Gross Margin (2021-2026)
- 8.19.4 Aesculap Biopsy Forceps Product Portfolio
- 8.19.5 Aesculap Recent Developments
- 8.20 Jinzhong
- 8.20.1 Jinzhong Company Information
- 8.20.2 Jinzhong Business Overview
- 8.20.3 Jinzhong Biopsy Forceps Sales, Value and Gross Margin (2021-2026)
- 8.20.4 Jinzhong Biopsy Forceps Product Portfolio
- 8.20.5 Jinzhong Recent Developments
- 8.21 Xinhua
- 8.21.1 Xinhua Company Information
- 8.21.2 Xinhua Business Overview
- 8.21.3 Xinhua Biopsy Forceps Sales, Value and Gross Margin (2021-2026)
- 8.21.4 Xinhua Biopsy Forceps Product Portfolio
- 8.21.5 Xinhua Recent Developments
- 8.22 Tonglu Medical
- 8.22.1 Tonglu Medical Company Information
- 8.22.2 Tonglu Medical Business Overview
- 8.22.3 Tonglu Medical Biopsy Forceps Sales, Value and Gross Margin (2021-2026)
- 8.22.4 Tonglu Medical Biopsy Forceps Product Portfolio
- 8.22.5 Tonglu Medical Recent Developments
- 8.23 Guangdian
- 8.23.1 Guangdian Company Information
- 8.23.2 Guangdian Business Overview
- 8.23.3 Guangdian Biopsy Forceps Sales, Value and Gross Margin (2021-2026)
- 8.23.4 Guangdian Biopsy Forceps Product Portfolio
- 8.23.5 Guangdian Recent Developments
- 8.24 Shenda
- 8.24.1 Shenda Company Information
- 8.24.2 Shenda Business Overview
- 8.24.3 Shenda Biopsy Forceps Sales, Value and Gross Margin (2021-2026)
- 8.24.4 Shenda Biopsy Forceps Product Portfolio
- 8.24.5 Shenda Recent Developments
- 8.25 Kangji
- 8.25.1 Kangji Company Information
- 8.25.2 Kangji Business Overview
- 8.25.3 Kangji Biopsy Forceps Sales, Value and Gross Margin (2021-2026)
- 8.25.4 Kangji Biopsy Forceps Product Portfolio
- 8.25.5 Kangji Recent Developments
- 8.26 Jinbaolong
- 8.26.1 Jinbaolong Company Information
- 8.26.2 Jinbaolong Business Overview
- 8.26.3 Jinbaolong Biopsy Forceps Sales, Value and Gross Margin (2021-2026)
- 8.26.4 Jinbaolong Biopsy Forceps Product Portfolio
- 8.26.5 Jinbaolong Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Biopsy Forceps Value Chain Analysis
- 9.1.1 Biopsy Forceps Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Biopsy Forceps Sales Mode & Process
- 9.2 Biopsy Forceps Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Biopsy Forceps Distributors
- 9.2.3 Biopsy Forceps Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst